Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 755

1.

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.

Brahmer JR, Lacchetti C, Schneider BJ, Atkins MB, Brassil KJ, Caterino JM, Chau I, Ernstoff MS, Gardner JM, Ginex P, Hallmeyer S, Holter Chakrabarty J, Leighl NB, Mammen JS, McDermott DF, Naing A, Nastoupil LJ, Phillips T, Porter LD, Puzanov I, Reichner CA, Santomasso BD, Seigel C, Spira A, Suarez-Almazor ME, Wang Y, Weber JS, Wolchok JD, Thompson JA.

J Clin Oncol. 2018 Feb 14:JCO2017776385. doi: 10.1200/JCO.2017.77.6385. [Epub ahead of print]

PMID:
29442540
2.

Retrospective Chart Review of the Triage Algorithm for Psychiatric Screening (TAPS) for Patients Who Present to Emergency Departments With Psychiatric Chief Complaints.

Schieferle Uhlenbrock J, Hudson J, Prewitt J, Thompson JA, Pereira K.

J Emerg Nurs. 2018 Jan 19. pii: S0099-1767(17)30423-3. doi: 10.1016/j.jen.2017.12.008. [Epub ahead of print]

PMID:
29370946
3.

Tumor infiltrating BRAFV600E-specific CD4 T cells correlated with complete clinical response in melanoma.

Veatch JR, Lee SM, Fitzgibbon M, Chow IT, Jesernig B, Schmitt T, Kong YY, Kargl J, Houghton AM, Thompson JA, McIntosh M, Kwok WW, Riddell SR.

J Clin Invest. 2018 Jan 23. pii: 98689. doi: 10.1172/JCI98689. [Epub ahead of print]

4.

Pembrolizumab plus pegylated interferon alfa-2b or ipilimumab for advanced melanoma or renal cell carcinoma: dose-finding results from the phase 1b KEYNOTE-029 study.

Atkins MB, Hodi FS, Thompson JA, McDermott D, Hwu WJ, Lawrence DP, Dawson NA, Wong DJL, Bhatia S, James M, Jain L, Robey S, Shu X, Homet Moreno B, Perini RF, Choueiri TK, Ribas A.

Clin Cancer Res. 2018 Jan 22. pii: clincanres.3436.2017. doi: 10.1158/1078-0432.CCR-17-3436. [Epub ahead of print]

PMID:
29358500
5.

Ophthalmic Complications Following Acoustic Neuroma Resection.

Gange WS, Kirchner ID, Thompson JA, Hill J, Grahnke K, Ibrahim T, Leonetti JP, Anderson DE, Bouchard CS.

Oper Neurosurg (Hagerstown). 2018 Jan 1;14(1):58-65. doi: 10.1093/ons/opx071.

PMID:
29253289
6.

Approaches to neuromodulation for schizophrenia.

Gault JM, Davis R, Cascella NG, Saks ER, Corripio-Collado I, Anderson WS, Olincy A, Thompson JA, Pomarol-Clotet E, Sawa A, Daskalakis ZJ, Lipsman N, Abosch A.

J Neurol Neurosurg Psychiatry. 2017 Dec 14. pii: jnnp-2017-316946. doi: 10.1136/jnnp-2017-316946. [Epub ahead of print] Review.

PMID:
29242310
7.

A First-in-Human Phase 1 Study of Subcutaneous Outpatient Recombinant Human IL-15 (rhIL-15) in Adults with Advanced Solid Tumors.

Miller JS, Morishima C, McNeel DG, Patel MR, Kohrt HE, Thompson JA, Sondel PM, Wakelee HA, Disis ML, Kaiser JC, Cheever MA, Streicher H, Creekmore SP, Waldmann TA, Conlon KC.

Clin Cancer Res. 2017 Dec 4. pii: clincanres.2451.2017. doi: 10.1158/1078-0432.CCR-17-2451. [Epub ahead of print]

PMID:
29203590
8.

The genetic profile of Leber congenital amaurosis in an Australian cohort.

Thompson JA, De Roach JN, McLaren TL, Montgomery HE, Hoffmann LH, Campbell IR, Chen FK, Mackey DA, Lamey TM.

Mol Genet Genomic Med. 2017 Nov;5(6):652-667. doi: 10.1002/mgg3.321. Epub 2017 Aug 22.

9.

Global and Targeted Pathway Impact of Gliomas on White Matter Integrity Based on Lobar Localization.

Ormond DR, D'Souza S, Thompson JA.

Cureus. 2017 Sep 7;9(9):e1660. doi: 10.7759/cureus.1660.

10.

Merkel cell carcinoma: Current US incidence and projected increases based on changing demographics.

Paulson KG, Park SY, Vandeven NA, Lachance K, Thomas H, Chapuis AG, Harms KL, Thompson JA, Bhatia S, Stang A, Nghiem P.

J Am Acad Dermatol. 2018 Mar;78(3):457-463.e2. doi: 10.1016/j.jaad.2017.10.028. Epub 2017 Nov 2.

PMID:
29102486
11.

Curative and palliative MRI-guided laser ablation for drug-resistant epilepsy.

Brown MG, Drees C, Nagae LM, Thompson JA, Ojemann S, Abosch A.

J Neurol Neurosurg Psychiatry. 2017 Oct 30. pii: jnnp-2017-316003. doi: 10.1136/jnnp-2017-316003. [Epub ahead of print] Review.

PMID:
29084870
12.

HIV-1 viral load and resistance in genital secretions in patients taking protease-inhibitor-based second-line therapy in Africa.

Hoppe A, Giuliano M, Lugemwa A, Thompson JA, Floridia M, Walker AS, Senoga I, Abwola MC, Pirillo MF, Kityo CM, Arenas-Pinto A, Paton NI; EARNEST Trial Team.

Antivir Ther. 2017 Oct 12. doi: 10.3851/IMP3200. [Epub ahead of print]

PMID:
29021409
13.

Sample Size Calculations for Population Size Estimation Studies Using Multiplier Methods With Respondent-Driven Sampling Surveys.

Fearon E, Chabata ST, Thompson JA, Cowan FM, Hargreaves JR.

JMIR Public Health Surveill. 2017 Sep 14;3(3):e59. doi: 10.2196/publichealth.7909.

14.

Sleep patterns in Parkinson's disease: direct recordings from the subthalamic nucleus.

Thompson JA, Tekriwal A, Felsen G, Ozturk M, Telkes I, Wu J, Ince NF, Abosch A.

J Neurol Neurosurg Psychiatry. 2018 Jan;89(1):95-104. doi: 10.1136/jnnp-2017-316115. Epub 2017 Sep 2.

PMID:
28866626
15.

The optimal design of stepped wedge trials with equal allocation to sequences and a comparison to other trial designs.

Thompson JA, Fielding K, Hargreaves J, Copas A.

Clin Trials. 2017 Dec;14(6):639-647. doi: 10.1177/1740774517723921. Epub 2017 Aug 10.

16.

Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): an open-label, phase 1b trial.

Long GV, Atkinson V, Cebon JS, Jameson MB, Fitzharris BM, McNeil CM, Hill AG, Ribas A, Atkins MB, Thompson JA, Hwu WJ, Hodi FS, Menzies AM, Guminski AD, Kefford R, Kong BY, Tamjid B, Srivastava A, Lomax AJ, Islam M, Shu X, Ebbinghaus S, Ibrahim N, Carlino MS.

Lancet Oncol. 2017 Sep;18(9):1202-1210. doi: 10.1016/S1470-2045(17)30428-X. Epub 2017 Jul 17.

PMID:
28729151
17.

Use of the Putamen as a Surrogate Anatomical Marker for the Internal Segment of the Globus Pallidus in Deep Brain Stimulation Surgery.

Thompson JA, Yin D, Ojemann SG, Abosch A.

Stereotact Funct Neurosurg. 2017;95(4):229-235. doi: 10.1159/000478105. Epub 2017 Jul 21.

PMID:
28728152
18.

Accelerating root system phenotyping of seedlings through a computer-assisted processing pipeline.

Dupuy LX, Wright G, Thompson JA, Taylor A, Dekeyser S, White CP, Thomas WTB, Nightingale M, Hammond JP, Graham NS, Thomas CL, Broadley MR, White PJ.

Plant Methods. 2017 Jul 13;13:57. doi: 10.1186/s13007-017-0207-1. eCollection 2017.

19.

Genetic Deletion of NADPH Oxidase 1 Rescues Microvascular Function in Mice With Metabolic Disease.

Thompson JA, Larion S, Mintz JD, Belin de Chantemèle EJ, Fulton DJ, Stepp DW.

Circ Res. 2017 Aug 18;121(5):502-511. doi: 10.1161/CIRCRESAHA.116.309965. Epub 2017 Jul 6.

PMID:
28684629
20.

Use of intraoperative local field potential spectral analysis to differentiate basal ganglia structures in Parkinson's disease patients.

Kolb R, Abosch A, Felsen G, Thompson JA.

Physiol Rep. 2017 Jun;5(12). pii: e13322. doi: 10.14814/phy2.13322.

21.

Bias and inference from misspecified mixed-effect models in stepped wedge trial analysis.

Thompson JA, Fielding KL, Davey C, Aiken AM, Hargreaves JR, Hayes RJ.

Stat Med. 2017 Oct 15;36(23):3670-3682. doi: 10.1002/sim.7348. Epub 2017 May 28.

22.

Altered ion transport in normal human bronchial epithelial cells following exposure to chemically distinct metal welding fume particles.

Fedan JS, Thompson JA, Meighan TG, Zeidler-Erdely PC, Antonini JM.

Toxicol Appl Pharmacol. 2017 Jul 1;326:1-6. doi: 10.1016/j.taap.2017.04.008. Epub 2017 Apr 12.

PMID:
28411035
23.

Metronidazole for the treatment of Tritrichomonas foetus in bulls.

Love D, Fajt VR, Hairgrove T, Jones M, Thompson JA.

BMC Vet Res. 2017 Apr 14;13(1):107. doi: 10.1186/s12917-017-0999-2.

24.

Optic Radiation Tractography and Visual Field Deficits in Laser Interstitial Thermal Therapy for Amygdalohippocampectomy in Patients with Mesial Temporal Lobe Epilepsy.

Yin D, Thompson JA, Drees C, Ojemann SG, Nagae L, Pelak VS, Abosch A.

Stereotact Funct Neurosurg. 2017;95(2):107-113. doi: 10.1159/000454866. Epub 2017 Mar 22.

25.

Academic Cancer Center Phase I Program Development.

Frankel AE, Flaherty KT, Weiner GJ, Chen R, Azad NS, Pishvaian MJ, Thompson JA, Taylor MH, Mahadevan D, Lockhart AC, Vaishampayan UN, Berlin JD, Smith DC, Sarantopoulos J, Riese M, Saleh MN, Ahn C, Frenkel EP.

Oncologist. 2017 Apr;22(4):369-374. doi: 10.1634/theoncologist.2016-0409. Epub 2017 Mar 17.

26.

A second chance for success with BRAF and MEK inhibitors in melanoma.

Paulson KG, Thompson JA.

Lancet Oncol. 2017 Apr;18(4):418-419. doi: 10.1016/S1470-2045(17)30151-1. Epub 2017 Mar 4. No abstract available.

PMID:
28268065
27.

A Multisensor Algorithm Predicts Heart Failure Events in Patients With Implanted Devices: Results From the MultiSENSE Study.

Boehmer JP, Hariharan R, Devecchi FG, Smith AL, Molon G, Capucci A, An Q, Averina V, Stolen CM, Thakur PH, Thompson JA, Wariar R, Zhang Y, Singh JP.

JACC Heart Fail. 2017 Mar;5(3):216-225. doi: 10.1016/j.jchf.2016.12.011.

28.

Mutation increasing β-carotene concentrations does not adversely affect concentrations of essential mineral elements in pepper fruit.

Tomlekova NB, White PJ, Thompson JA, Penchev EA, Nielen S.

PLoS One. 2017 Feb 16;12(2):e0172180. doi: 10.1371/journal.pone.0172180. eCollection 2017.

29.

REM sleep behaviour disorder: prodromal and mechanistic insights for Parkinson's disease.

Tekriwal A, Kern DS, Tsai J, Ince NF, Wu J, Thompson JA, Abosch A.

J Neurol Neurosurg Psychiatry. 2017 May;88(5):445-451. doi: 10.1136/jnnp-2016-314471. Epub 2016 Dec 13. Review.

PMID:
27965397
30.

Evolutionary origins of abnormally large shoot sodium accumulation in nonsaline environments within the Caryophyllales.

White PJ, Bowen HC, Broadley MR, El-Serehy HA, Neugebauer K, Taylor A, Thompson JA, Wright G.

New Phytol. 2017 Apr;214(1):284-293. doi: 10.1111/nph.14370. Epub 2016 Dec 5.

31.
32.

Implementation of a Recovery-Oriented Training Program for Psychiatric Nurses in the Inpatient Setting: A Mixed-Methods Hospital Quality Improvement Study.

Repique RJ, Vernig PM, Lowe J, Thompson JA, Yap TL.

Arch Psychiatr Nurs. 2016 Dec;30(6):722-728. doi: 10.1016/j.apnu.2016.06.003. Epub 2016 Jun 23.

PMID:
27888966
33.

The regulatory α and β subunits of phosphorylase kinase directly interact with its substrate, glycogen phosphorylase.

Thompson JA, Carlson GM.

Biochem Biophys Res Commun. 2017 Jan 8;482(2):221-225. doi: 10.1016/j.bbrc.2016.11.044. Epub 2016 Nov 11.

34.

Ecological impacts and management implications of reef walking on a tropical reef flat community.

Williamson JE, Byrnes EE, Clark JA, Connolly DM, Schiller SE, Thompson JA, Tosetto L, Martinelli JC, Raoult V.

Mar Pollut Bull. 2017 Jan 30;114(2):742-750. doi: 10.1016/j.marpolbul.2016.10.069. Epub 2016 Nov 4.

PMID:
27817886
35.

Biomechanical Effects of an Injury Prevention Program in Preadolescent Female Soccer Athletes.

Thompson JA, Tran AA, Gatewood CT, Shultz R, Silder A, Delp SL, Dragoo JL.

Am J Sports Med. 2017 Feb;45(2):294-301. doi: 10.1177/0363546516669326. Epub 2016 Oct 29.

36.

Age-Related Differences in Gait Kinematics, Kinetics, and Muscle Function: A Principal Component Analysis.

Schloemer SA, Thompson JA, Silder A, Thelen DG, Siston RA.

Ann Biomed Eng. 2017 Mar;45(3):695-710. doi: 10.1007/s10439-016-1713-4. Epub 2016 Aug 29.

PMID:
27573696
37.

NCCN Guidelines Insights: Melanoma, Version 3.2016.

Coit DG, Thompson JA, Algazi A, Andtbacka R, Bichakjian CK, Carson WE 3rd, Daniels GA, DiMaio D, Fields RC, Fleming MD, Gastman B, Gonzalez R, Guild V, Johnson D, Joseph RW, Lange JR, Martini MC, Materin MA, Olszanski AJ, Ott P, Gupta AP, Ross MI, Salama AK, Skitzki J, Swetter SM, Tanabe KK, Torres-Roca JF, Trisal V, Urist MM, McMillian N, Engh A.

J Natl Compr Canc Netw. 2016 Aug;14(8):945-58.

PMID:
27496110
38.

Recurrent Inhibition to the Medial Nucleus of the Trapezoid Body in the Mongolian Gerbil (Meriones Unguiculatus).

Dondzillo A, Thompson JA, Klug A.

PLoS One. 2016 Aug 4;11(8):e0160241. doi: 10.1371/journal.pone.0160241. eCollection 2016.

39.

Mesencephalic representations of recent experience influence decision making.

Thompson JA, Costabile JD, Felsen G.

Elife. 2016 Jul 25;5. pii: e16572. doi: 10.7554/eLife.16572.

40.

Muscle Forces and Their Contributions to Vertical and Horizontal Acceleration of the Center of Mass During Sit-to-Stand Transfer in Young, Healthy Adults.

Caruthers EJ, Thompson JA, Chaudhari AM, Schmitt LC, Best TM, Saul KR, Siston RA.

J Appl Biomech. 2016 Oct;32(5):487-503. doi: 10.1123/jab.2015-0291. Epub 2016 Aug 19.

PMID:
27341083
41.

Pressor recovery after acute stress is impaired in high fructose-fed Lean Zucker rats.

Thompson JA, D'Angelo G, Mintz JD, Fulton DJ, Stepp DW.

Physiol Rep. 2016 Jun;4(12). pii: e12758. doi: 10.14814/phy2.12758.

42.

The effect of foot landing position on biomechanical risk factors associated with anterior cruciate ligament injury.

Tran AA, Gatewood C, Harris AH, Thompson JA, Dragoo JL.

J Exp Orthop. 2016 Dec;3(1):13. doi: 10.1186/s40634-016-0049-1. Epub 2016 Jun 18.

43.

Immunocytochemical organization and sour taste activation in the rostral nucleus of the solitary tract of mice.

Stratford JM, Thompson JA, Finger TE.

J Comp Neurol. 2017 Feb 1;525(2):271-290. doi: 10.1002/cne.24059. Epub 2016 Aug 11.

44.

Outcomes in Patients With Metastatic Renal Cell Carcinoma Who Develop Everolimus-Related Hyperglycemia and Hypercholesterolemia: Combined Subgroup Analyses of the RECORD-1 and REACT Trials.

Bono P, Oudard S, Bodrogi I, Hutson TE, Escudier B, Machiels JP, Thompson JA, Figlin RA, Ravaud A, Basaran M, Porta C, Bracarda S, Brechenmacher T, Lin C, Voi M, Grunwald V, Motzer RJ.

Clin Genitourin Cancer. 2016 Oct;14(5):406-414. doi: 10.1016/j.clgc.2016.04.011. Epub 2016 Apr 27.

45.

T-Cell Therapy Using Interleukin-21-Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor Regression.

Chapuis AG, Roberts IM, Thompson JA, Margolin KA, Bhatia S, Lee SM, Sloan HL, Lai IP, Farrar EA, Wagener F, Shibuya KC, Cao J, Wolchok JD, Greenberg PD, Yee C.

J Clin Oncol. 2016 Nov 1;34(31):3787-3795. doi: 10.1200/JCO.2015.65.5142.

46.

Combined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient.

Chapuis AG, Lee SM, Thompson JA, Roberts IM, Margolin KA, Bhatia S, Sloan HL, Lai I, Wagener F, Shibuya K, Cao J, Wolchok JD, Greenberg PD, Yee C.

J Exp Med. 2016 Jun 27;213(7):1133-9. doi: 10.1084/jem.20152021. Epub 2016 May 30.

47.

Major Changes in Systemic Therapy for Advanced Melanoma.

Thompson JA.

J Natl Compr Canc Netw. 2016 May;14(5 Suppl):638-40.

PMID:
27226502
48.

Hydroxyapatite-doped alginate beads as scaffolds for the osteoblastic differentiation of mesenchymal stem cells.

Wang MO, Bracaglia L, Thompson JA, Fisher JP.

J Biomed Mater Res A. 2016 Sep;104(9):2325-33. doi: 10.1002/jbm.a.35768. Epub 2016 May 17.

PMID:
27129735
49.

PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.

Nghiem PT, Bhatia S, Lipson EJ, Kudchadkar RR, Miller NJ, Annamalai L, Berry S, Chartash EK, Daud A, Fling SP, Friedlander PA, Kluger HM, Kohrt HE, Lundgren L, Margolin K, Mitchell A, Olencki T, Pardoll DM, Reddy SA, Shantha EM, Sharfman WH, Sharon E, Shemanski LR, Shinohara MM, Sunshine JC, Taube JM, Thompson JA, Townson SM, Yearley JH, Topalian SL, Cheever MA.

N Engl J Med. 2016 Jun 30;374(26):2542-52. doi: 10.1056/NEJMoa1603702. Epub 2016 Apr 19.

50.

PD-1 Blockade in Melanoma: A Promising Start, but a Long Way to Go.

Bhatia S, Thompson JA.

JAMA. 2016 Apr 19;315(15):1573-5. doi: 10.1001/jama.2016.4012. No abstract available.

PMID:
27092829

Supplemental Content

Loading ...
Support Center